Advertisement
Loading...

Sera Prognostics, Inc.

SERANASDAQ
Healthcare
Medical - Diagnostics & Research
$1.72
$-0.07(-3.91%)
U.S. Market opens in 36h 39m

Sera Prognostics, Inc. Fundamental Analysis

Sera Prognostics, Inc. (SERA) shows moderate financial fundamentals with a PE ratio of -2.78, profit margin of -563.86%, and ROE of -41.02%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 5.19%.

Key Strengths

Cash Position54.83%
PEG Ratio-0.07
Current Ratio2.12

Areas of Concern

ROE-41.02%
Operating Margin-642.35%
We analyze SERA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -42296.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-42296.5/100

We analyze SERA's fundamental strength across five key dimensions:

Efficiency Score

Weak

SERA struggles to generate sufficient returns from assets.

ROA > 10%
-34.36%

Valuation Score

Excellent

SERA trades at attractive valuation levels.

PE < 25
-2.78
PEG Ratio < 2
-0.07

Growth Score

Excellent

SERA delivers strong and consistent growth momentum.

Revenue Growth > 5%
5.19%
EPS Growth > 10%
32.32%

Financial Health Score

Excellent

SERA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
2.12

Profitability Score

Weak

SERA struggles to sustain strong margins.

ROE > 15%
-4101.63%
Net Margin ≥ 15%
-563.86%
Positive Free Cash Flow
No

Key Financial Metrics

Is SERA Expensive or Cheap?

P/E Ratio

SERA trades at -2.78 times earnings. This suggests potential undervaluation.

-2.78

PEG Ratio

When adjusting for growth, SERA's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Sera Prognostics, Inc. at 1.32 times its book value. This may indicate undervaluation.

1.32

EV/EBITDA

Enterprise value stands at -2.15 times EBITDA. This is generally considered low.

-2.15

How Well Does SERA Make Money?

Net Profit Margin

For every $100 in sales, Sera Prognostics, Inc. keeps $-563.86 as profit after all expenses.

-563.86%

Operating Margin

Core operations generate -642.35 in profit for every $100 in revenue, before interest and taxes.

-642.35%

ROE

Management delivers $-41.02 in profit for every $100 of shareholder equity.

-41.02%

ROA

Sera Prognostics, Inc. generates $-34.36 in profit for every $100 in assets, demonstrating efficient asset deployment.

-34.36%

Following the Money - Real Cash Generation

Operating Cash Flow

Sera Prognostics, Inc. generates limited operating cash flow of $-20.40M, signaling weaker underlying cash strength.

$-20.40M

Free Cash Flow

Sera Prognostics, Inc. generates weak or negative free cash flow of $-20.95M, restricting financial flexibility.

$-20.95M

FCF Per Share

Each share generates $-0.55 in free cash annually.

$-0.55

FCF Yield

SERA converts -41.74% of its market value into free cash.

-41.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.78

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.32

vs 25 benchmark

P/S Ratio

Price to sales ratio

1192.63

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.12

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.41

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

-0.52

vs 25 benchmark

How SERA Stacks Against Its Sector Peers

MetricSERA ValueSector AveragePerformance
P/E Ratio-2.7828.62 Better (Cheaper)
ROE-41.02%783.00% Weak
Net Margin-56385.96%-48181.00% (disorted) Weak
Debt/Equity0.040.39 Strong (Low Leverage)
Current Ratio2.124.12 Strong Liquidity
ROA-34.36%-21914.00% (disorted) Weak

SERA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sera Prognostics, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

23.09%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

38.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

42.29%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ